| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
BASIC SCIENCE INVESTIGATIONS |
Divisions of Nuclear Medicine, Thoracic Surgery, and Pulmonary Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
The aim of this study was to investigate the difference in the rates of FDG uptake between malignant and inflammatory cells and processes. Methods: In vitro studies: 18F-FDG uptake by different tumor cell lines (human mesothelioma [REN]; rat mesothelioma [II45]; mice melanoma [B18F10]; mice mesothelioma [AB12]; human myeloma [GM1500]; and human ovarian cancer [SKOV3]) and peripheral blood mononuclear cells isolated from 8 healthy human volunteers was measured 20 and 60 min after FDG was added into growth medium. Animal studies: II45 cells were implanted into the left flank of rats (n = 5) and a focal inflammatory reaction (mechanical irritation) was generated in the right flank. PET images at 45 and 90 min after injection of FDG were obtained and standardized uptake values (SUVs) were determined. Patient studies: Seventy-six patients who had dual time FDG PET scans were retrospectively analyzed. All results were expressed as the percentage change in SUV of the later time image from that of the earlier time (mean ± SD). Results: In vitro studies: Except for the SKOV3 cell line, which had only minimally increased FDG uptake (+10% ± 26%; P > 0.3), all other tumor cell lines tested showed significantly increased FDG uptake over time (GM1500, +59% ± 19%; B18F10, +81% ± 15%; AB12, 93% ± 21%; II45, +161% ± 21%; REN, +198% ± 48%; P < 0.01 for all). By contrast, FDG uptake in mononuclear cells was decreased in 7 of 8 donors. Animal studies: SUVs of tumors from 90-min images were significantly higher than those from 45-min images (+18% ± 8%; P < 0.01), whereas the SUVs of inflammatory lesions decreased over time (-17% ± 13% of the early images; P < 0.05). Clinical studies: The SUVs of delayed images from the known malignant lesions compared with those of earlier scans increased over time (+19.18% ± 9.58%; n = 31; P < 0.001; 95% confidence interval, 15.8%–22.6%). By contrast, the SUVs of benign lung nodules decreased slightly over time (-6.3% ± 8.1%; n = 12; P < 0.05; 95% confidence interval, -10.9% to -1.7%). The SUV of inflammatory lesions caused by radiation therapy (+1.16% ± 7.23%; n = 8; P > 0.05; 95% confidence interval, -3.9%–6.2%) and the lesions of painful lower limb prostheses (+4.03% ± 11.32%; n = 25; P > 0.05; 95% confidence interval, -0.4%–8.5%) remained stable over time. Conclusion: These preliminary data show that dual time imaging appears to be useful in distinguishing malignant from benign lesions. Further research is necessary to confirm these results.
Key Words: PET • FDG • dual time point imaging • malignancy • inflammation • standardized uptake value
This article has been cited by other articles:
|
|
 |
|
  C.-J. Chen, B.-F. Lee, W.-J. Yao, L. Cheng, P.-S. Wu, C. L. Chu, and N.-T. Chiu Dual-Phase 18F-FDG PET in the Diagnosis of Pulmonary Nodules with an Initial Standard Uptake Value Less Than 2.5 Am. J. Roentgenol., August 1, 2008; 191(2): 475 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Nakagawa, M. Yamada, and Y. Suzuki 18F-FDG Uptake in Reactive Neck Lymph Nodes of Oral Cancer: Relationship to Lymphoid Follicles J. Nucl. Med., July 1, 2008; 49(7): 1053 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Pipitone, A. Versari, and C. Salvarani Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update Rheumatology, April 1, 2008; 47(4): 403 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kumar, S. Basu, D. Torigian, V. Anand, H. Zhuang, and A. Alavi Role of Modern Imaging Techniques for Diagnosis of Infection in the Era of 18F-Fluorodeoxyglucose Positron Emission Tomography Clin. Microbiol. Rev., January 1, 2008; 21(1): 209 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-K. Chen, C.-T. Su, K.-H. Chi, R.-H. Cheng, S.-C. Wang, and C.-H. Hsu Utility of 18F-FDG PET/CT Uptake Patterns in Waldeyer's Ring for Differentiating Benign from Malignant Lesions in Lateral Pharyngeal Recess of Nasopharynx J. Nucl. Med., January 1, 2007; 48(1): 8 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mavi, M. Urhan, J. Q. Yu, H. Zhuang, M. Houseni, T. F. Cermik, D. Thiruvenkatasamy, B. Czerniecki, M. Schnall, and A. Alavi Dual Time Point 18F-FDG PET Imaging Detects Breast Cancer with High Sensitivity and Correlates Well with Histologic Subtypes J. Nucl. Med., September 1, 2006; 47(9): 1440 - 1446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Pawlik, J. J. Erasmus, M. T. Truong, H. Macapinlac, M. I. Ross, and J. E. Gershenwald Acne vulgaris: false-positive finding on integrated 18F-FDG PET/CT in a patient with melanoma. Am. J. Roentgenol., July 1, 2006; 187(1): W117 - W119. [Full Text] [PDF]
|
|
|
|
|
|
Y. Nishiyama, Y. Yamamoto, K. Fukunaga, N. Kimura, A. Miki, Y. Sasakawa, H. Wakabayashi, K. Satoh, and M. Ohkawa Dual-Time-Point 18F-FDG PET for the Evaluation of Gallbladder Carcinoma J. Nucl. Med., April 1, 2006; 47(4): 633 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hashimoto, T. Tsujikawa, C. Kondo, M. Maki, M. Momose, A. Nagai, T. Ohnuki, T. Nishikawa, and K. Kusakabe Accuracy of PET for Diagnosis of Solid Pulmonary Lesions with 18F-FDG Uptake Below the Standardized Uptake Value of 2.5 J. Nucl. Med., March 1, 2006; 47(3): 426 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bunyaviroch and R. E. Coleman PET Evaluation of Lung Cancer J. Nucl. Med., March 1, 2006; 47(3): 451 - 469. [Full Text] [PDF]
|
|
|
|
|
|
R. Kumar, V. A. Loving, A. Chauhan, H. Zhuang, S. Mitchell, and A. Alavi Potential of Dual-Time-Point Imaging to Improve Breast Cancer Diagnosis with 18F-FDG PET J. Nucl. Med., November 1, 2005; 46(11): 1819 - 1824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Reinhardt, H. Strunk, T. Gerhardt, R. Roedel, U. Jaeger, J. Bucerius, T. Sauerbruch, H.-J. Biersack, and F. L. Dumoulin Detection of Klatskin's Tumor in Extrahepatic Bile Duct Strictures Using Delayed 18F-FDG PET/CT: Preliminary Results for 22 Patient Studies J. Nucl. Med., July 1, 2005; 46(7): 1158 - 1163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Kelloff, J. M. Hoffman, B. Johnson, H. I. Scher, B. A. Siegel, E. Y. Cheng, B. D. Cheson, J. O'Shaughnessy, K. Z. Guyton, D. A. Mankoff, et al. Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development Clin. Cancer Res., April 15, 2005; 11(8): 2785 - 2808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Schrevens, N. Lorent, C. Dooms, and J. Vansteenkiste The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer Oncologist, November 1, 2004; 9(6): 633 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Spence, M. Muzi, D. A. Mankoff, S. F. O'Sullivan, J. M. Link, T. K. Lewellen, B. Lewellen, P. Pham, S. Minoshima, K. Swanson, et al. 18F-FDG PET of Gliomas at Delayed Intervals: Improved Distinction Between Tumor and Normal Gray Matter J. Nucl. Med., October 1, 2004; 45(10): 1653 - 1659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Truong, J. J. Erasmus, H. A. Macapinlac, and D. A. Podoloff Teflon Injection for Vocal Cord Paralysis: False-Positive Finding on FDG PET-CT in a Patient with Non-Small Cell Lung Cancer Am. J. Roentgenol., June 1, 2004; 182(6): 1587 - 1589. [Full Text] [PDF]
|
|
|
|
 |
|
 S-H Liu, J T Chang, S-H Ng, S-C Chan, and T-C Yen False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient Br. J. Radiol., March 1, 2004; 77(915): 257 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. J. Wang, G. P. Reddy, M. B. Gotway, C. B. Higgins, D. M. Jablons, M. Ramaswamy, R. A. Hawkins, and W. R. Webb Malignant Pleural Mesothelioma: Evaluation with CT, MR Imaging, and PET RadioGraphics, January 1, 2004; 24(1): 105 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V H Gerbaudo, S Britz-Cunningham, D J Sugarbaker, and S T Treves Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma Thorax, December 1, 2003; 58(12): 1077 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Y. Ma, L.-C. See, C.-H. Lai, H.-H. Chou, C.-S. Tsai, K.-K. Ng, S. Hsueh, W.-J. Lin, J.-T. Chen, and T.-C. Yen Delayed 18F-FDG PET for Detection of Paraaortic Lymph Node Metastases in Cervical Cancer Patients J. Nucl. Med., November 1, 2003; 44(11): 1775 - 1783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. van Westreenen, P. A.M. Heeren, P. L. Jager, H. M. van Dullemen, H. Groen, and J. Th.M. Plukker Pitfalls of Positive Findings in Staging Esophageal Cancer With F-18-Fluorodeoxyglucose Positron Emission Tomography Ann. Surg. Oncol., November 1, 2003; 10(9): 1100 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A Yeretsian, T. M. Blodgett, B. F Branstetter IV, M. M Roberts, and C. C. Meltzer Teflon-Induced Granuloma: A False-Positive Finding with PET Resolved with Combined PET and CT AJNR Am. J. Neuroradiol., June 1, 2003; 24(6): 1164 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Demura, T. Tsuchida, T. Ishizaki, S. Mizuno, Y. Totani, S. Ameshima, I. Miyamori, M. Sasaki, and Y. Yonekura 18F-FDG Accumulation with PET for Differentiation Between Benign and Malignant Lesions in the Thorax J. Nucl. Med., April 1, 2003; 44(4): 540 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Hoffmann, H Vogelsang, K Kletter, G Zettinig, A Chott, and M Raderer 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma Gut, March 1, 2003; 52(3): 347 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. H. Gerbaudo, D. J. Sugarbaker, S. Britz-Cunningham, M. F. Di Carli, C. Mauceri, and S. T. Treves Assessment of Malignant Pleural Mesothelioma with 18F-FDG Dual-Head Gamma-Camera Coincidence Imaging: Comparison with Histopathology J. Nucl. Med., September 1, 2002; 43(9): 1144 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Matthies, M. Hickeson, A. Cuchiara, and A. Alavi Dual Time Point 18F-FDG PET for the Evaluation of Pulmonary Nodules J. Nucl. Med., July 1, 2002; 43(7): 871 - 875. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
